Citation Impact
Citing Papers
The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men: a novel demonstration
2008 StandoutNobel
Bone grafts and biomaterials substitutes for bone defect repair: A review
2017 Standout
Bone regeneration: current concepts and future directions
2011 Standout
SKG mice, a new genetic model of rheumatoid arthritis
2003 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Daidzein Is More Efficient than Genistein in Preventing Ovariectomy-Induced Bone Loss in Rats
2000
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
1999 Standout
Osteoporosis
2019 Standout
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Who's afraid of the big bad Wolff?: “Wolff's law” and bone functional adaptation
2006 Standout
Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice
2001
Mechanical Strain and Bone Cell Function: A Review
2002
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Bone Tissue Engineering: State of the Art and Future Trends
2004 Standout
Dietary Polyphenols and the Prevention of Diseases
2005 Standout
The control of fracture healing and its therapeutic targeting: Improving upon nature
2009
Osteoarthritis: A disease of the joint as an organ
2012 Standout
Discovery of CP-533536: An EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation
2009
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Transcriptional regulation by calcium, calcineurin, and NFAT
2003 Standout
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
High-dose estrogen-induced osteogenesis in the mouse is partially suppressed by indomethacin
1999
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Cannabinoids Stimulate Fibroblastic Colony Formation by Bone Marrow Cells Indirectly via CB2 Receptors
2007
The P2X7 Nucleotide Receptor Mediates Skeletal Mechanotransduction
2005
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.
1998
Skeletal remodeling in health and disease
2007 Standout
Mechanisms of Action and Therapeutic Potential of Strontium in Bone
2001
Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing
2005
Mechanotransduction and the functional response of bone to mechanical strain
1995
Ankylosing spondylitis
2007 Standout
Cellular, molecular, and tissue-level reactions to orthodontic force
2006 Standout
Bone Tissue Engineering: Recent Advances and Challenges
2012 Standout
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis
2002 Standout
Chronic arthritis leads to disturbances in the bone collagen network
2010 StandoutNobel
Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction
2019
Osteoclast differentiation and activation
2003 StandoutNature
Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats
2004
Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats
2010
Periodontitis: a polymicrobial disruption of host homeostasis
2010 Standout
Suppression of bone formation by osteoclastic expression of semaphorin 4D
2011 Standout
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2β)-Null Mice
2008
Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease
2011
Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone
1997
Moderate and severe traumatic brain injury in adults
2008 Standout
Toward a Mathematical Description of Bone Biology: The Principle of Cellular Accommodation
1999
Bone's mechanostat: A 2003 update
2003
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
2002 Standout
The role of CD8+ T‐cell replicative senescence in human aging
2005
Estrogen Actions in the Central Nervous System1
1999 Standout
Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease
2001
The ongoing saga of osteoporosis treatment
1998
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
1998 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody
2013
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial
2016
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
CD4 + T Cells and the Proinflammatory Cytokines Gamma Interferon and Interleukin-6 Contribute to Alveolar Bone Loss in Mice
1999
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Basic Guide to the Mechanisms of Antiestrogen Action
1998
Effects of XT-44, a Phosphodiesterase 4 Inhibitor, in Osteoblastgenesis and Osteoclastgenesis in Culture and Its Therapeutic Effects in Rat Osteopenia Models
1999
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Generation and reproductive phenotypes of mice lacking estrogen receptor β
1998 StandoutNobel
Drug delivery therapies I
2002
An EP2 receptor-selective prostaglandin E2agonist induces bone healing
2003
Mechanisms of Estrogen Action
2001 Standout
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Estrogen-induced osteogenesis in intact female mice lacking ERβ
2002 StandoutNobel
Nature’s hierarchical materials
2007 Standout
TENSEGRITY: THE ARCHITECTURAL BASIS OF CELLULAR MECHANOTRANSDUCTION
1997 Standout
Bone modeling: biomechanics, molecular mechanisms, and clinical perspectives
2004
The amazing osteocyte
2010 Standout
Identification of Estrogen Receptor β2, A Functional Variant of Estrogen Receptor β Expressed in Normal Rat Tissues
1998
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Vascular Calcification
2006 Standout
Bone Morphogenetic Protein 2 Induces Cyclo-oxygenase 2 in Osteoblasts via a Cbfa1 Binding Site: Role in Effects of Bone Morphogenetic Protein 2 In Vitro and In Vivo
2002
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Perspective: genetic and hormonal roles in bone disorders: insights of an updated bone physiology.
2003
Calcineurin regulates bone formation by the osteoblast
2005
Works of Y.F. Ma being referenced
Effect of the Interaction of Parathyroid Hormone and Cyclosporine A on Bone Mineral Metabolism in the Rat
2001
Maintenance therapy for added bone mass or how to keep the profit after withdrawal of therapy of osteopenia
1995
Parathyroid hormone therapy accelerates recovery from immobilization-induced osteopenia
1995
Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats
1995
Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain
1999
Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in rats
1995
Early effects of prostaglandin E2 on bone formation and resorption in different bone sites of rats
1995
Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model
1997
Transforming growth factor-β administration modifies cyclosporine A-induced bone loss
2001
The in vivo anabolic actions of prostaglandins in bone
1997
Prostaglandin E2 restores cancellous bone to immobilized limb and adds bone to overloaded limb in right hindlimb immobilization rats
1993
T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.
1996
Prostaglaridin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats
1994
Effects of on/off anabolic hPTH and remodelling inhibitors on metaphyseal bone of immobilized rat femurs. Tomographical (pQCT) description and correlation with histomorphometric changes in tibial cancellous bone
1995
Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats
1995